Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
OPERATING ACTIVITIES:
Net income	$ 124,268	$ 451,956
Adjustment to reconcile net loss to net cash provided by operating activities:
Gain from forgiveness of debt and interest		(449,294)
Derivative liability loss (gain)	(544,017)	(562,995)
Loss on issuance of notes payable		154,355
Depreciation	2,596	2,598
Amortization of debt discounts	49,863	261,682
Changes in operating assets and liabilities:
Accounts receivable		(40,000)
Interest receivable	(8,822)	(277)
Prepaid director’s compensation		12,000
Loans receivable	847	(14,598)
Accounts payable	17,590	(1,395)
Accrued interest	15,176	48,042
Accrued director’s compensation	18,074
Net cash (used in) provided by operating activities	(324,425)	(137,926)
INVESTING ACTIVITIES:
Notes receivable-long-term		(150,000)
Net cash (used in) investing activities		(150,000)
FINANCING ACTIVITIES:
Issuance of stock for Regulation A financing		740,150
Repayments under loans payable-related parties		(405)
Repayments under notes payable		(26,597)
Borrowings from notes payable		136,250
Net cash provided by (used in) financing activities		849,398
NET INCREASE IN CASH AND CASH EQUIVALENTS	(324,425)	561,472
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	324,494	56,300
CASH AND CASH EQUIVALENTS, END OF PERIOD	69	617,772
Supplemental Disclosures of Cash Flow Information:
Taxes paid
Interest paid
Non-cash investing and financing activities:
Cancellation of common stock and stock to be issued		68,000
Cancellation of common stock as per court order		299,100
Issuance of common stock for debt and accrued interest		$ 206,382